CSPR Virtual Town Hall Meeting
Saturday, December 5, 10:00 am – 12:00 pm
Stay informed through open discussion and updates: CA PR program update – Trina Limberg, Discussion on PR programming during resurge of COVID-19 pandemic, Guest speaker at 11:15 am – Dr. Mark Avdalovic, specialist in pulmonary and critical care medicine and UC Davis Health associate professor of clinical medicine.
Reserve your spot!
Updates on Health Policy and Reimbursement
|
September 23, 2020
AACVPR: Health Policy & Reimbursement Update Delivery of Cardiac and Pulmonary Rehabilitation – Opportunities During the COVID-19 Pandemic |
October 9, 2020
AACVPR: Health Policy & Reimbursement Update Extension of COVID-19 Pandemic extends Opportunities for Delivery of Cardiac and Pulmonary Rehabilitation |
October 20, 2020
AACVPR: Health Policy & Reimbursement Update CMS adds cardiac, intensive cardiac, and pulmonary rehabilitation to telehealth codes for physician office-based programs during the Public Health Emergency |
TAKE OUR SHORT SURVEY
CSPR and your colleagues are thinking about you during this challenging time. We are hoping to understand the impact of the pandemic and shelter in place as a starting point of developing strategies for CA Pulmonary Rehabilitation providers and patients. Please help us by answering questions in our short survey. Thank you in advance for your help.
|
|
|
|
Vital Signs, Oxygen, & Exercise Prescription. How are these impacted by COVID-19 By Ellen Hillegass
CMS WAIVES IN-PERSON TESTING FOR MEDICARE OXYGEN PATIENTS
COVID-19 and Telehealth update from AACVPR
CMS Rejects Telehealth Reimbursement for CR/PR
The COVID-19 pandemic has had a huge impact on cardiac and pulmonary rehabilitation professionals and our patients.…Read AACVPR Update |
You can find more information on Guide on Telehealth codes on the AACVPR & Centers for Medicare & Medicaid ServicesMedicare & Medicaid Services (CMS) – Medicare Coverage and Payment of Virtual Services
|
European Respiratory Society
Please see the link below for an important resource from the European Respiratory Society Ad-hoc International Task Force who have published an expert-based opinion on early- and short-term rehabilitation interventions in COVID-19 survivors. It will be updated at least every two weeks. The group welcomes input from the rehabilitation community via this link:
Coronavirus Disease 2019 (COVID-19)
Healthcare Professional Resources
Coronavirus Disease 2019 (COVID-19)
Patient Resources
American Thoracic Society
What to do When Pulmonary Rehabilitation (PR) is Unavailable
PATIENT EDUCATION | INFORMATION SERIES
|
American Thoracic Society
What is the Novel 2019-nCoV Coronavirus?
PATIENT HEALTH | INFORMATION SERIES
|
American Thoracic Society
Novel Wuhan (2019-nCOV) Coronavirus
PUBLIC HEALTH | INFORMATION SERIES
|
CSPR 2020 Annual Conference April 30, 2020 (Pre–Conference) May 1—2, 2020
The CSPR conference will NOT take place as scheduled on April 30 (Pre-Conference) and May 1-2 due to concerns with the coronavirus COVID-19. CSPR is currently in communication with Hilton to determine future planning. Refunds will be provided. We will continue to update you. On behalf of CSPR we would like to thank you for your continued support. If you have any questions, please feel free to contact us. Please stay healthy and safe.
CSPR is a Joint Affiliate of AACVPR
Joint Affiliate (JA) CSPR/AACVPR Membership
Join today and get two memberships – CSPR & AACVPR.
Become a joint affiliate member now. Your membership cycle will be July 1, 2019 to June 30, 2020.
Need help accessing CSPR Members Only pages?
LATEST CSPR NEWS
OUR OBJECTIVES
|
Education
To support the efforts of other organizations having similar interests to those of CSPR. |
Awareness
To support the efforts of other organizations having similar interests to those of CSPR. |
Communication
To support the efforts of other organizations having similar interests to those of CSPR. |
Development
To develop recommendations for guidelines of care for pulmonary rehabilitation programs. |
Advocacy
To support the efforts of other organizations having similar interests to those of CSPR. |
UPCOMING MEETINGS & EVENTS
At this time, the nation has cancelled in person meetings and events, however, there's a rich source of webinars/webcasts that come with your CSPR/JA membership.
Check out AACVPR's Events & Education and Resources.
CSPR is joining the Call to Action with the American Thoracic Society (ATS) to improve Pulmonary Rehabilitation awareness
Additional information is available at LIVEBETTER.ORG
|
|
Bulletin for ATS PR Assembly
Please review and share with colleagues!
Pulmonary rehabilitation is known to improve quality of life for patients with COPD and other lung diseases. The problem? Not enough patients, or their doctors, know about this treatment option.
To help address that knowledge gap, the ATS has partnered with the Gawlicki Family Foundation to launch a pilot program to increase public awareness of pulmonary rehab. At the center of the campaign is a new, patient-friendly website: www.livebetter.org.
On the website, visitors will find a number of resources to help patients (and their family, friends, caregivers and doctors) answer an important question: Is pulmonary rehab right for me? Related resources, include:
Resources explaining pulmonary rehab and its benefits
Directory of pulmonary rehab programs across the United States
Criteria for selecting a PR Program and the enrollment process
Patient stories
Frequently Asked Questions
The campaign is also being promoted through a public relations campaign. Here are a few recent news articles which were subsequently published in numerous other news outlets:
Physician's Briefing: "Patients Hospitalized for COPD Rarely Receive Pulmonary Rehab," November 16, 2016
Everyday Health: "Most COPD Patients Are Missing Out on Pulmonary Rehab Benefits," December 6, 2018
Please share these resources, most especially www.livebetter.org, a related fact sheet and the attached social media posts, with your colleagues, patients and their families. ATS also has a Patient Education Information Series fact sheet on this topic.
Pulmonary rehab can deliver real benefits and we want as many people as possible to know.
To help address that knowledge gap, the ATS has partnered with the Gawlicki Family Foundation to launch a pilot program to increase public awareness of pulmonary rehab. At the center of the campaign is a new, patient-friendly website: www.livebetter.org.
On the website, visitors will find a number of resources to help patients (and their family, friends, caregivers and doctors) answer an important question: Is pulmonary rehab right for me? Related resources, include:
Resources explaining pulmonary rehab and its benefits
Directory of pulmonary rehab programs across the United States
Criteria for selecting a PR Program and the enrollment process
Patient stories
Frequently Asked Questions
The campaign is also being promoted through a public relations campaign. Here are a few recent news articles which were subsequently published in numerous other news outlets:
Physician's Briefing: "Patients Hospitalized for COPD Rarely Receive Pulmonary Rehab," November 16, 2016
Everyday Health: "Most COPD Patients Are Missing Out on Pulmonary Rehab Benefits," December 6, 2018
Please share these resources, most especially www.livebetter.org, a related fact sheet and the attached social media posts, with your colleagues, patients and their families. ATS also has a Patient Education Information Series fact sheet on this topic.
Pulmonary rehab can deliver real benefits and we want as many people as possible to know.
REIMBURSEMENT UPDATES
Pulmonary Rehabilitation Reimbursement Challenges and Strategies for Survival by Chris Garvey, et al.
Despite growing evidence for the clinical effectiveness of Pulmonary Rehabilitation (PR), inadequate reimbursement and limited availability continue to hinder the effective PR delivery in the US.(1) A recent analysis indicates that, in 2012, only 3.7% of Medicare-eligible COPD patients received PR (2). Low reimbursement undeniably influences the availability of what is now the standard of care in chronic lung disease.
